Leukoplakia
What's New
Last Posted: Sep 13, 2024
- Association between 35 blood and urine biomarkers and oral leukoplakia: a two-sample Mendelian randomization study.
Yu-Long Ouyang, et al. Frontiers in oncology 2024 0 1437493 - Genome-wide characterization of the mutational landscape of proliferative verrucous leukoplakia.
Camile S Farah, et al. Oral surgery, oral medicine, oral pathology and oral radiology 2024 0 - Polymorphisms associated with oral clefts as potential markers for oral pre and malignant disorders.
Adriana Mendonça da Silva, et al. Oral diseases 2023 0 - A scientometric study of tobacco and alcohol use as risk factors for oral cavity health.
Hao Liu, et al. Journal of dental sciences 2023 0 (4) 1883-1888 - The Taq 1 polymorphism of Vitamin D receptor gene is associated with oral cancer and preoral cancer in North Indian population.
Nigam Kumud, et al. Journal of cancer research and therapeutics 2023 0 (2) 403-407 - IL17A and IL17RA gene polymorphisms in Fanconi anemia.
Mobile Rafael Zancan, et al. Brazilian oral research 2023 0 e012 - Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias.
Anne Anuhya, et al. Cytogenetic and genome research 2023 0 - The Microbiome of Potentially Malignant Oral Leukoplakia Exhibits Enrichment for Fusobacterium, Leptotrichia, Campylobacter, and Rothia Species.
Amer Abdrazak, et al. Frontiers in microbiology 2017 0 2391 - Effect of Frequency and Duration of Tobacco Use on Oral Mucosal Lesions – A Cross-Sectional Study among Tobacco Users in Hyderabad, India.
Aishwarya K Monisha, et al. Asian Pacific journal of cancer prevention : APJCP 2017 0 (8) 2233-2238 - Factors affecting Clinical Outcomes after Treatment of Oral Leukoplakia with CO and Diode Laser.
Galletta Vivian, et al. The journal of contemporary dental practice 2017 0 (9) 775-780
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: